421 related articles for article (PubMed ID: 28283286)
1. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial.
Lye DC; Archuleta S; Syed-Omar SF; Low JG; Oh HM; Wei Y; Fisher D; Ponnampalavanar SSL; Wijaya L; Lee LK; Ooi EE; Kamarulzaman A; Lum LC; Tambyah PA; Leo YS
Lancet; 2017 Apr; 389(10079):1611-1618. PubMed ID: 28283286
[TBL] [Abstract][Full Text] [Related]
2. Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.
Mittelman M; Platzbecker U; Afanasyev B; Grosicki S; Wong RSM; Anagnostopoulos A; Brenner B; Denzlinger C; Rossi G; Nagler A; Garcia-Delgado R; Portella MSO; Zhu Z; Selleslag D
Lancet Haematol; 2018 Jan; 5(1):e34-e43. PubMed ID: 29241762
[TBL] [Abstract][Full Text] [Related]
3. Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective Study.
Archuleta S; Chia PY; Wei Y; Syed-Omar SF; Low JG; Oh HM; Fisher D; Ponnampalavanar SSL; Wijaya L; Kamarulzaman A; Lum LCS; Tambyah PA; Leo YS; Lye DC
Clin Infect Dis; 2020 Jul; 71(2):383-389. PubMed ID: 31626692
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.
Sun L; Wang J; Shao L; Yuan C; Zhao H; Li D; Wang Z; Han P; Yu Y; Xu M; Zhao H; Qiu J; Zhou H; Liu X; Hou Y; Peng J; Hou M
Lancet Haematol; 2021 Apr; 8(4):e289-e298. PubMed ID: 33770484
[TBL] [Abstract][Full Text] [Related]
7. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection.
Lye DC; Lee VJ; Sun Y; Leo YS
Clin Infect Dis; 2009 May; 48(9):1262-5. PubMed ID: 19292665
[TBL] [Abstract][Full Text] [Related]
8. Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study.
Bussel JB; de Miguel PG; Despotovic JM; Grainger JD; Sevilla J; Blanchette VS; Krishnamurti L; Connor P; David M; Boayue KB; Matthews DC; Lambert MP; Marcello LM; Iyengar M; Chan GW; Chagin KD; Theodore D; Bailey CK; Bakshi KK
Lancet Haematol; 2015 Aug; 2(8):e315-25. PubMed ID: 26688484
[TBL] [Abstract][Full Text] [Related]
9. Potential Harm of Prophylactic Platelet Transfusion in Adult Dengue Patients.
Lee TH; Wong JG; Leo YS; Thein TL; Ng EL; Lee LK; Lye DC
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004576. PubMed ID: 27015272
[TBL] [Abstract][Full Text] [Related]
10. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
Grainger JD; Locatelli F; Chotsampancharoen T; Donyush E; Pongtanakul B; Komvilaisak P; Sosothikul D; Drelichman G; Sirachainan N; Holzhauer S; Lebedev V; Lemons R; Pospisilova D; Ramenghi U; Bussel JB; Bakshi KK; Iyengar M; Chan GW; Chagin KD; Theodore D; Marcello LM; Bailey CK
Lancet; 2015 Oct; 386(10004):1649-58. PubMed ID: 26231455
[TBL] [Abstract][Full Text] [Related]
11. Role of platelet transfusion in children with bleeding in dengue fever.
Pothapregada S; Kamalakannan B; Thulasingam M
J Vector Borne Dis; 2015 Dec; 52(4):304-8. PubMed ID: 26714510
[TBL] [Abstract][Full Text] [Related]
12. Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial.
Mir O; Cropet C; Toulmonde M; Cesne AL; Molimard M; Bompas E; Cassier P; Ray-Coquard I; Rios M; Adenis A; Italiano A; Bouché O; Chauzit E; Duffaud F; Bertucci F; Isambert N; Gautier J; Blay JY; Pérol D;
Lancet Oncol; 2016 May; 17(5):632-41. PubMed ID: 27068858
[TBL] [Abstract][Full Text] [Related]
13. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.
Oliva EN; Alati C; Santini V; Poloni A; Molteni A; Niscola P; Salvi F; Sanpaolo G; Balleari E; Germing U; Fenaux P; Stamatoullas A; Palumbo GA; Salutari P; Impera S; Avanzini P; Cortelezzi A; Liberati AM; Carluccio P; Buccisano F; Voso MT; Mancini S; Kulasekararaj A; Morabito F; Bocchia M; Cufari P; Spiriti MA; Santacaterina I; D'Errigo MG; Bova I; Zini G; Latagliata R
Lancet Haematol; 2017 Mar; 4(3):e127-e136. PubMed ID: 28162984
[TBL] [Abstract][Full Text] [Related]
14. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
15. Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.
Feng FE; Feng R; Wang M; Zhang JM; Jiang H; Jiang Q; Lu J; Liu H; Peng J; Hou M; Shen JL; Wang JW; Xu LP; Liu KY; Huang XJ; Zhang XH
Lancet Haematol; 2017 Oct; 4(10):e487-e496. PubMed ID: 28917657
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial.
van de Weerdt EK; Biemond BJ; Zeerleder SS; van Lienden KP; Binnekade JM; Vlaar APJ;
Trials; 2018 Feb; 19(1):127. PubMed ID: 29463280
[TBL] [Abstract][Full Text] [Related]
17. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of prophylactic platelet transfusion in patients with dengue: A retrospective study of patients at a tertiary care hospital in Karachi.
Sethi SM; Khalil A; Naseem Khan MR; Khatri A; ; Muhammad AJ; Murtaza G
J Pak Med Assoc; 2017 Sep; 67(9):1374-1378. PubMed ID: 28924277
[TBL] [Abstract][Full Text] [Related]
19. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
20. When less is more: can we abandon prophylactic platelet transfusion in Dengue fever?
Kurukularatne C; Dimatatac F; Teo DL; Lye DC; Leo YS
Ann Acad Med Singap; 2011 Dec; 40(12):539-45. PubMed ID: 22294065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]